Colgate Palmolive (CL) Liabilities and Shareholders Equity (2009 - 2026)

Colgate Palmolive has reported Liabilities and Shareholders Equity for 18 years, with the latest figure at $16.8 billion in Q2 2026.

• Liabilities and Shareholders Equity for Q2 2026 came in at $16.8 billion, down 3.89% year-over-year; the trailing twelve-month figure through Jun 2026 was $67.2 billion (changed 0.46% YoY), and the FY2025 annual result was $16.3 billion, up 1.77% from the prior year.
• Liabilities and Shareholders Equity grew to $16.8 billion in Q2 2026, from $16.6 billion in the prior quarter.
• Over five years, Liabilities and Shareholders Equity peaked at $17.5 billion in Q3 2025 and troughed at $15.7 billion in Q2 2022.
• A 5-year average of $16.4 billion and a median of $16.4 billion in 2023 frame the typical range for Liabilities and Shareholders Equity.
• The widest annual swing landed in 2025, when Liabilities and Shareholders Equity advanced 6.01%; it then fell 3.89% in 2026.
• A 5-year view of Liabilities and Shareholders Equity shows it stood at $15.7 billion in 2022, then rose by 4.21% to $16.4 billion in 2023, then decreased by 2.12% to $16.0 billion in 2024, then rose by 1.77% to $16.3 billion in 2025, then gained by 2.82% to $16.8 billion in 2026.
• Per Business Quant data, the three most recent Liabilities and Shareholders Equity figures were $16.8 billion in Q2 2026, $16.6 billion in Q1 2026, and $16.3 billion in Q4 2025.